65,437 trials
Hypoparathyroidism · Hypocalcemia · Autoimmune Polyendocrine Syndrome Type 1
Primary: Mean Serum Calcium in Children and Young Adults — 2.02; 1.88 mmol/liter — p=0.02
Reflexology · Migraine · Pain
Primary: Visual Analog Scale (VAS) — 4.15; 7.46 Score (0-10)
Reflux Esophagitis · Gastric Ulcer · Duodenal Ulcer
Primary: Presence/Absence of Reflux Esophagitis Relapse — 0; 1; 7; 18 Participants
Insomnia
Primary: Insomnia Severity Index — 5.4 Scores on a scale
Intraoperative Bleeding · Hemorrhage, Surgical · Liver Diseases
Primary: Rate of Hemostasis at 3 Minutes Without Rebleeding at the 10-minute Time Point — 81; 33 Participants
Type 2 Diabetes
Primary: Change in Time in Range 3.9-10.0 mmol/L (70-180 mg/dL) — 20.3; 8.3 percentage points — p=0.001
Type 2 Diabetes
Primary: Phase 1 Change in CGM-derived Time in Range (TIR) — 25; 16 % of time in 24 hours
HIV
Primary: Proportion of Participants Who Remain on PRO 140 Monotherapy Regimen at the End of Week 48 Without Experiencing Virologic Failure — 0.23; 0.43; 0.45 proportion of…
Tobacco Product Beliefs and Use
Primary: General Relative Harm Perception — 3.04; 2.76; 2.84; 3.19 score on a scale
Clostridioides Difficile Infection · Stool Microbiome · Organ Dysfunction Syndrome
Primary: The Superiority of Bezlotoxumab Over Placebo to Reduce the Occurence of an Unfavorable Outcome by Day 40. — 7; 16 Participants — p=0.015
Stroke · Upper Extremity Paresis · Hemiplegia
Primary: Change in Box and Blocks Test (BBT) at 6 Months Post-Treatment — 5.1; 4.2; 3.0 blocks
Labor Pain
Primary: Placement Below L3 Vertebra — 49; 49 Participants
Primary Aldosteronism · Hyperaldosteronism
Primary: Number of Treatment Emergent Adverse Events — 27; 34; 101 Number of events
ST Elevation Myocardial Infarction
Primary: The Percentage of Eligible Patients Who Agreed to Participate in the Study. — 40 Participants
Suicide, Attempted · Suicide, Ideation · Depression
Primary: Columbia Suicide Severity Rating Scale (CSSRS) - Visit 1 — 2.08; 2.37 points